Clinical Trial Update: Oxaliplatin in Treating Women With Advanced or Metastatic Breast Cancer That Has Not Responded to Previous Chemotherapy [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating oxaliplatin in women with advanced or metastatic breast cancer that has not responded to prior chemotherapy has been terminated. The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Breast Cancer | Phase 2 | Status: TERMINATED